Marlan D. Walker is CEO at TherapeuticsMD, Inc. (TXMD). They have made 7 open-market trades across 1 company since 2021, most recently 2025-04-14.
CIK 0001820187
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $2K since 2025, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXMD | 73,639 | $134K |
Shares reported on the most recent Form 4, priced at the 2025-04-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXMD | BUY | 2025-04-14 | 2025-04-15 | $1.00 | $490 | +17.3% | +40.4% | +12.5% |
| TXMD | BUY | 2025-04-09 | 2025-04-10 | $0.86 | $2K | +23.1% | +68.8% | +39.1% |
| TXMD | SELL | 2023-12-06 | 2023-12-07 | $2.29 | $44K | +9.7% | +9.2% | +13.4% |
| TXMD | SELL | 2023-04-26 | 2023-05-04 | $3.64 | $3K | +8.9% | +7.9% | +3.2% |
| TXMD | SELL | 2023-04-12 | 2023-04-14 | $3.65 | $4K | -5.9% | +17.1% | +5.1% |
| TXMD | SELL | 2022-12-06 | 2022-12-09 | $4.95 | $5K | -4.8% | -17.1% | -32.2% |
| TXMD | SELL | 2021-05-11 | 2021-05-12 | $1.04 | $22K | +18.4% | +28.2% | -10.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.